These results indicated that I-CRP is a selective cell death inductor in T-ALL cells, which does not affect healthy cells at same doses and times of treatment, thus confirming the selective cytotoxic effect in cancer cells. The gene discussed is CRP; the disease is acute lymphoblastic leukemia.